Table 1 Lipid species in the serum of CUB patients ranked by effect size, ER negative compared to ER positive.
Order | Variable | ER_Negaitve_Effect_compared_to_ER_Positive |
|---|---|---|
1 | CE(18:2) | 97.76 |
2 | PC(16:0/18:2) | 51.96 |
3 | SM(20:0) | 42.09 |
4 | TAG54:6-FA18:2 | 28.78 |
5 | SM(22:0) | 23.33 |
6 | PC(16:0/18:1) | 23.13 |
7 | CE(16:1) | 20.32 |
8 | TAG54:5-FA18:2 | 16.57 |
9 | SM(22:1) | 16.01 |
10 | CE(18:3) | 15.51 |
11 | FFA(18:2) | 15.37 |
12 | PC(18:0/18:2) | 13.77 |
14 | PC(18:1/18:2) | 12.38 |
14 | TAG52:4-FA18:2 | 11.37 |
15 | TAG54:5-FA18:1 | 10.83 |